Capital Fund Management S.A. Pfizer Inc Call Options Transaction History

Capital Fund Management S.A.

$34.4 Billion
Q1 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $52.1 Million - $59.8 Million	-2,012,000 Reduced 34.1%	3,888,700 $108 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $51.3 Million - $66.6 Million	1,963,700 Added 49.88%	5,900,700 $170 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $38.4 Million - $44.9 Million	1,196,300 Added 43.65%	3,937,000 $131 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $9.23 Million - $10.7 Million	-255,600 Reduced 8.53%	2,740,700 $101 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $85 Million - $111 Million	2,158,400 Added 257.6%	2,996,300 $122 Million

Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $27.1 Million - $35.3 Million	-648,500 Reduced 43.63%	837,900 $43 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $20.9 Million - $25.5 Million	478,000 Added 47.4%	1,486,400 $65 Billion
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $43.1 Million - $51.1 Million	-926,200 Reduced 47.88%	1,008,400 $52.9 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $5.42 Million - $6.71 Million	118,400 Added 6.52%	1,934,600 $100 Million
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $32.3 Million - $47.8 Million	781,000 Added 75.44%	1,816,200 $107 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $40.6 Million - $52.2 Million	1,035,200 New	1,035,200 $44.5 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $515,746 - $581,658	-15,400 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $1.02 Million - $1.3 Million	-30,600 Reduced 66.52%	15,400 $566,000
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $590,550 - $692,850	-18,600 Reduced 28.79%	46,000 $1.6 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $32.8 Million - $39.8 Million	-1,088,400 Reduced 94.4%	64,600 $2 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $9.57 Million - $13.7 Million	-354,100 Reduced 23.5%	1,153,000 $35.7 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $8.55 Million - $9.7 Million	259,700 Added 20.82%	1,507,100 $59 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $28.7 Million - $37.3 Million	884,500 Added 243.73%	1,247,400 $44.8 Million
Q2 2019 Aug 12, 2019	SELL	$36.98 - $41.52 $6.39 Million - $7.17 Million	-172,700 Reduced 32.24%	362,900 $15.7 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $25.4 Million - $27.9 Million	-676,300 Reduced 55.8%	535,600 $22.7 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $6.22 Million - $7.1 Million	161,800 Added 15.41%	1,211,900 $52.9 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $33.6 Million - $40.8 Million	975,800 Added 1313.32%	1,050,100 $46.3 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $306,714 - $326,987	-9,300 Reduced 11.12%	74,300 $2.7 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $8.01 Million - $9.29 Million	-251,000 Reduced 75.01%	83,600 $2.97 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $8.9 Million - $9.45 Million	267,700 Added 400.15%	334,600 $12.1 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $2.07 Million - $2.28 Million	66,900	66,900 $2.39 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

Vanguard Group Inc Valley Forge, PA

507M
Shares

$14.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

431M
Shares

$12.1 Billion
0.28% of portfolio
State Street Corp Boston, MA

291M
Shares

$8.13 Billion
0.37% of portfolio
Wellington Management Group LLP Boston, MA

178M
Shares

$4.97 Billion
0.89% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

122M
Shares

$3.42 Billion
0.79% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account